User profiles for Michelle J. Groome

Michelle Groome

University of the Witwatersrand
Verified email at wits-vida.org
Cited by 11376

Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa

…, A von Gottberg, C Cohen, MJ Groome, J Dushoff… - Science, 2022 - science.org
We provide two methods for monitoring reinfection trends in routine surveillance data to identify
signatures of changes in reinfection risk and apply these approaches to data from South …

[HTML][HTML] Safety and immunogenicity of a parenteral P2-VP8-P [8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo …

MJ Groome, A Koen, A Fix, N Page, L Jose… - The Lancet Infectious …, 2017 - thelancet.com
Background Efficacy of live oral rotavirus vaccines is reduced in low-income compared with
high-income settings. Parenteral non-replicating rotavirus vaccines might offer benefits over …

[HTML][HTML] Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

…, N Andrews, R Araos, Y Goldberg, MJ Groome… - The lancet, 2022 - thelancet.com
Background Knowing whether COVID-19 vaccine effectiveness wanes is crucial for
informing vaccine policy, such as the need for and timing of booster doses. We aimed to …

[HTML][HTML] Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial

MJ Groome, L Fairlie, J Morrison, A Fix… - The Lancet Infectious …, 2020 - thelancet.com
Background A monovalent, parenteral, subunit rotavirus vaccine was well tolerated and
immunogenic in adults in the USA and in toddlers and infants in South Africa, but elicited poor …

[HTML][HTML] Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study

…, HP Endtz, N Fancourt, W Fu, D Goswami, MJ Groome… - The Lancet, 2019 - thelancet.com
Background Pneumonia is the leading cause of death among children younger than 5 years.
In this study, we estimated causes of pneumonia in young African and Asian children, using …

Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study

MJ Groome, N Page, MM Cortese, J Moyes… - The Lancet Infectious …, 2014 - thelancet.com
Background The effectiveness of the rotavirus vaccine under conditions of routine use in an
African setting with a high prevalence of HIV infection needs to be established. We assessed …

[HTML][HTML] Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study

…, R Welch, L Ozougwu, MJ Groome… - The Lancet Global …, 2022 - thelancet.com
Background Up to the end of January, 2022, South Africa has had four recognisable COVID-19
pandemic waves, each predominantly dominated by one variant of concern: the …

[HTML][HTML] Clinical severity of SARS-CoV-2 Omicron BA. 4 and BA. 5 lineages compared to BA. 1 and Delta in South Africa

…, H Moultrie, MJ Groome, DG Amoako, J Everatt… - Nature …, 2022 - nature.com
Omicron lineages BA.4 and BA.5 drove a fifth wave of COVID-19 cases in South Africa. Here,
we use the presence/absence of the S-gene target as a proxy for SARS-CoV-2 variant/…

[HTML][HTML] Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series

…, SA Madhi, MJ Groome, C Cohen, J Moyes… - The Lancet Global …, 2017 - thelancet.com
Background Respiratory syncytial virus (RSV) infection is an important cause of pneumonia
mortality in young children. However, clinical data for fatal RSV infection are scarce. We …

[HTML][HTML] Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study

…, A Parker, J Nel, R Perumal, MJ Groome… - The Lancet Global …, 2022 - thelancet.com
Background Post COVID-19 condition (PCC), as defined by WHO, refers to a wide range of
new, returning, or ongoing health problems in people who have had COVID-19, and it …